Crohn Disease Clinical Trials in San Diego, California

5 studies are recruiting for crohn disease in San Diego, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

   The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Medical Associates Research Group, Inc., San Diego, California

   Locations

   370 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT07196722 on ClinicalTrials.gov

2. A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

   The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with moderately to severely active Crohn's Disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Medical Associates Research Group, Inc., San Diego, California

   Locations

   160 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT07499232 on ClinicalTrials.gov

3. A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

   The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active Crohn's disease (a long-term, progressive [worsens with time] and life-threatening disease of the intesti…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Medical Associates Research Group, Inc., San Diego, California

   Locations

   142 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT07577843 on ClinicalTrials.gov

4. Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

   Crohn's disease (CD) is a condition that causes inflammation (swelling, redness) of the lining and wall of the small intestine, large intestine, or both. CD may be associated with abdominal cramps/pain, diarrhea, blood in the stool, weight loss, or delayed growth in children. While the exact cause …

   Stage

   Phase 4

   Ages

   6 to 17

   Site

   Rady Children's Hospital - San Diego and University of California, San Diego, San Diego, California

   Locations

   26 in total

   Run by

   Connecticut Children's Medical Center

   See if you can join NCT05781152 on ClinicalTrials.gov

5. Precise Infliximab Exposure and Pharmacodynamic Control

   Approximately 3 million people in the United States are living with inflammatory bowel disease, which includes Crohn's Disease (CD). There are limited treatment options approved for use in children and adults with Crohn's disease. Physicians need better ways to inform decisions on treatment. The ma…

   Stage

   Phase 2

   Ages

   6 to 22

   Site

   Rady Children's Hospital San Diego, San Diego, California

   Locations

   11 in total

   Run by

   Children's Hospital Medical Center, Cincinnati

   See if you can join NCT05660746 on ClinicalTrials.gov